title: Differential RNA expression of the pS2 gene in the human benign and malignant prostatic tissue.
abstract: OBJECTIVE
  The pS2 trefoil protein has been detected in close association with neuro-endocrine differentiation in prostate cancer and prostatic intraepithelial neoplasia. These preliminary results have suggested that pS2 is a candidate as a specific marker for prostate cancer tissue. To ascertain the specificity of pS2 in prostate cancer tissue, we have used an RT-PCR method from prostate biopsies provided from human malignant and benign prostatic hyperplasia (BPH) tissue.
  
  
  METHODS
  Prostate biopsies were obtained from transrectal biopsies from 153 patients with an abnormal DRE or a PSA more than 4 ng./ml. or symptoms of BPH and a PSA more than 4 ng./ml. Total RNA was extracted from fresh frozen specimens of tissue samples. Detection of pS2 transcript compared with GADPH transcripts was done using RT-PCR.
  
  
  RESULTS
  Biopsy results showed that 108 patients had prostate cancer (average Gleason score 6.39+/-0.74) and 45 patients had BPH. PS2 RT-PCR results showed that PS2 RNA expression was negative in 83% of the BPH cases. Conversely, 92% of prostate cancer specimens were positive (Chi-square: 86.09, p<0.001). There was no correlation with tumor stage or the Gleason score. Comparing the expression of pS2 in BPH and localized prostate cancer, we found a sensitivity of 92% and a specificity of 82%.
  
  
  CONCLUSIONS
  On this large sample of prostate biopsies from patients at risk of having prostate cancer, pS2 was demonstrated as an interesting marker significantly associated with prostate cancer. Further work on the expression of pS2 according to differentiation and hormonal status is in progress.
authors.affiliation: Département d'Anatomo Pathologie, Hôpital Edouard HERRIOT, Lyon, France.
authors.forename: M
authors.initials: M
authors.lastname: Colombel
authors.forename: R
authors.initials: R
authors.lastname: Dante
authors.forename: R
authors.initials: R
authors.lastname: Bouvier
authors.forename: S
authors.initials: S
authors.lastname: Ribieras
authors.forename: C
authors.initials: C
authors.lastname: Pangaud
authors.forename: J M
authors.initials: JM
authors.lastname: Marechal
authors.forename: Y
authors.initials: Y
authors.lastname: Lasne
mesh_terms: D004967:Estrogens / Q000235:genetics*; D015972:Gene Expression Regulation, Neoplastic / Q000235:genetics*; D006801:Humans; D008297:Male; D011470:Prostatic Hyperplasia / Q000235:genetics* / Q000378:metabolism*; D011471:Prostatic Neoplasms / Q000235:genetics* / Q000378:metabolism*; D011506:Proteins / Q000235:genetics*; D012333:RNA, Messenger / Q000096:biosynthesis*; D012680:Sensitivity and Specificity; D000071163:Trefoil Factor-1; D025521:Tumor Suppressor Proteins
chemical_list: D004967:Estrogens; D011506:Proteins; D012333:RNA, Messenger; C051838:TFF1 protein, human; D000071163:Trefoil Factor-1; D025521:Tumor Suppressor Proteins